• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment

cafead

Administrator
Staff member
  • cafead   Jul 20, 2020 at 12:13: PM
via Celltrion Group has commenced phase 1 human clinical study to assess the potential of its antiviral antibody treatment for patients with Covid-19.

article source